What is a stock summary page? Click here for an overview.
Business Description
Solventum Corp
NAICS : 923120
SIC : 7372
ISIN : US83444M1018
Compare
Compare
Traded in other countries / regions
SOLV.USAKB7.GermanySOLV.Mexico Index Membership
S&P 500Russell 1000Russell 3000 IPO Date
2024-03-26Description
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | 0.21 | |||||
| Debt-to-Equity | 2.71 | |||||
| Debt-to-EBITDA | 5.25 | |||||
| Interest Coverage | 2.82 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.53 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.1 | |||||
| 3-Year EBITDA Growth Rate | -15 | |||||
| 3-Year EPS without NRI Growth Rate | -7.5 | |||||
| 3-Year FCF Growth Rate | -25.4 | |||||
| 3-Year Book Growth Rate | -37.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.83 | |||||
| 9-Day RSI | 42.82 | |||||
| 14-Day RSI | 45.64 | |||||
| 3-1 Month Momentum % | 14.6 | |||||
| 6-1 Month Momentum % | 8.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 91.23 | |||||
| Days Sales Outstanding | 50.5 | |||||
| Days Payable | 54.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 1.04 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.65 | |||||
| Operating Margin % | 12.55 | |||||
| Net Margin % | 5.8 | |||||
| FCF Margin % | 9.75 | |||||
| ROE % | 9.76 | |||||
| ROA % | 3.31 | |||||
| ROIC % | 6.42 | |||||
| 3-Year ROIIC % | 76.46 | |||||
| ROC (Joel Greenblatt) % | 55.15 | |||||
| ROCE % | 8.01 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.17 | |||||
| Forward PE Ratio | 13.09 | |||||
| PE Ratio without NRI | 11.17 | |||||
| PS Ratio | 1.58 | |||||
| PB Ratio | 4.36 | |||||
| Price-to-Free-Cash-Flow | 16.02 | |||||
| Price-to-Operating-Cash-Flow | 10.89 | |||||
| EV-to-EBIT | 20.69 | |||||
| EV-to-EBITDA | 13.17 | |||||
| EV-to-Revenue | 2.44 | |||||
| EV-to-FCF | 25.12 | |||||
| Earnings Yield (Greenblatt) % | 4.83 | |||||
| FCF Yield % | 6.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:SOLV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Solventum Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8,254 | ||
| EPS (TTM) ($) | 2.75 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 45.64 | ||
| 14-Day ATR ($) | 2.687453 | ||
| 20-Day SMA ($) | 77.268 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 47.16 - 96.05 | ||
| Shares Outstanding (Mil) | 173 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Solventum Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Solventum Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Solventum Corp Frequently Asked Questions
What is Solventum Corp(SOLV)'s stock price today?
The current price of SOLV is $74.71. The 52 week high of SOLV is $96.05 and 52 week low is $47.16.
When is next earnings date of Solventum Corp(SOLV)?
The next earnings date of Solventum Corp(SOLV) is 2025-05-09 Est..
Does Solventum Corp(SOLV) pay dividends? If so, how much?
Solventum Corp(SOLV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers